MEGAN TILLMAN: Open Payments
NPI 1982141107 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,161 in 109 payments from 40 companies in 2025. Trend: 2023 $2,453 · 2024 $2,709 · 2025 $2,161
Food & beverage: $2,161
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $188 |
| E.R. Squibb & Sons, L.L.C. | 7 | $155 |
| Genentech USA, Inc. | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 6 | $136 |
| PFIZER INC. | 8 | $110 |
| ABBVIE INC. | 4 | $104 |
| GENZYME CORPORATION | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| JAZZ PHARMACEUTICALS INC. | 3 | $71 |
Products named: Enhertu, LIBTAYO, OPDIVO, XTANDI, BRUKINSA, Tecentriq, KEYTRUDA, OPDUALAG.
Industry payments across AL — which companies pay providers there.
